New targeted treatments for non-Hodgkin lymphoma
Precision next-generation radioimmunotherapies to Cure Non-Hodgkin Lymphoma
This study is working on new treatments for non-Hodgkin lymphoma using advanced antibodies that could be more effective and safer, with the hope of offering better options for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11050386 on NIH RePORTER |
What this research studies
This research focuses on developing advanced radioimmunotherapies specifically designed to treat non-Hodgkin lymphoma (NHL). By utilizing next-generation fully-human anti-CD20 antibodies, the research aims to create more effective and precise treatment options that can potentially lead to cures. The approach involves evaluating these novel therapies in preclinical models to ensure their safety and efficacy before moving to clinical trials. Patients may benefit from these innovative treatments that address the limitations of existing therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with non-Hodgkin lymphoma who have not responded adequately to existing therapies.
Not a fit: Patients with other types of cancers or those who do not have non-Hodgkin lymphoma may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide more effective and targeted treatment options for patients with non-Hodgkin lymphoma.
How similar studies have performed: Previous research has shown promise with first-generation radioimmunotherapies, indicating potential for success with these next-generation approaches.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Wahl, Richard Leo — Washington University
- Study coordinator: Wahl, Richard Leo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.